The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Buy(P) | 72K | $0.28 | $20K |
| Jul 25, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Grant(A) | 500K | — | $0 |
| Jul 25, 2025 | Eisenberg Anthony D. | Director | Grant(A) | 61K | — | $0 |
| Jul 25, 2025 | Lee Soo Young | Director | Grant(A) | 61K | — | $0 |
| May 19, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Buy(P) | 16K | $0.26 | $4K |
| Apr 29, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Buy(P) | 4K | $0.25 | $1K |
| Apr 24, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Buy(P) | 27K | $0.34 | $9K |
| Apr 23, 2025 | Suk Jin Wook (Miles) | CEO and Chairman, Director | Buy(P) | 7K | $0.28 | $2K |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 42K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 41K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 30K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 539K | — | $0 |
| Nov 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 1.1M | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 6.5M | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 987K | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 787K | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 787K | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 578K | — | $0 |
| Nov 13, 2024 | Chan Ian | Chief Executive Officer, Director, 10% Owner | Grant(A) | 777K | — | $0 |
| Nov 13, 2024 | Suk Jin Wook (Miles) | Co-CEO & Chairman, Director | Grant(A) | 614K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).